Mesa Laboratories Quarterly Balance Sheet
NASDAQ: MLABIndustrialsIndustrial Machinery/ComponentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Mesa Laboratories financial position
As of Jun 30, 2026, Mesa Laboratories reported total assets of $419.2 million, down 3.8% from a year earlier against total liabilities of $230.5 million. Shareholders' equity stood at $188.8 million, or 45.0% of assets. The company held $30.7 million in cash and equivalents against $66.1 million of debt, a net debt position of $35.4 million.
The current ratio (current assets divided by current liabilities) was 1.79, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.35.
Summary generated from market data by MetaCap's automated system. Methodology
Mesa Laboratories balance sheet (quarterly)
| Quarter (USD) | Q1 20272026-06-30 | Q4 20262026-03-31 | Q3 20252025-12-31 | Q2 20252025-09-30 | Q1 20252025-06-30 | Q4 20252025-03-31 | Q3 20252024-12-31 | Q2 20252024-09-30 | Q1 20252024-06-30 | Q4 20242024-03-31 | Q3 20242023-12-31 | Q2 20242023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 30.70M | 26.93M | 28.98M | 20.42M | 21.28M | 27.32M | 27.32M | 24.34M | 28.47M | 28.21M | 28.22M | 35.62M |
| Receivables | 34.41M | 44.10M | 40.23M | 40.09M | 39.07M | 41.97M | 41.97M | 40.23M | 35.57M | 39.05M | 36.02M | 36.34M |
| Inventory | 27.23M | 26.37M | 26.56M | 27.74M | 28.11M | 25.36M | 25.36M | 29.74M | 31.77M | 32.67M | 35.97M | 32.88M |
| Total Current Assets | 102.85M | 106.27M | 105.63M | 97.43M | 98.26M | 102.69M | 102.69M | 107.98M | 106.69M | 109.35M | 118.36M | 117.66M |
| Property, Plant & Equipment | 30.09M | 30.61M | 31.60M | 31.84M | 31.69M | 32.33M | 32.33M | 32.07M | 31.40M | 31.77M | 31.77M | 28.57M |
| Goodwill | 186.04M | 186.86M | 189.30M | 188.49M | 188.05M | 181.76M | 181.76M | 183.75M | 179.72M | 180.10M | 346.18M | 283.27M |
| Intangible Assets | 78.40M | 83.35M | 89.65M | 93.27M | 97.40M | 96.88M | 98.18M | 108.82M | 109.46M | 113.75M | 232.77M | 197.68M |
| Total Assets | 419.22M | 427.75M | 434.85M | 430.35M | 435.74M | 433.35M | 433.35M | 454.10M | 440.36M | 446.80M | 741.77M | 637.19M |
| Accounts Payable | 7.46M | 4.93M | 5.25M | 5.09M | 6.27M | 5.75M | 5.75M | 5.99M | 5.66M | 6.04M | 4.55M | 4.81M |
| Total Current Liabilities | 57.32M | 61.90M | 54.40M | 48.30M | 149.49M | 163.96M | 163.96M | 153.23M | 54.87M | 44.31M | 44.18M | 39.82M |
| Long-Term Debt | 66.09M | 67.50M | 68.44M | 69.38M | 70.31M | 71.25M | 72.19M | 73.13M | 74.06M | — | — | — |
| Total Liabilities | 230.46M | 241.50M | 248.16M | 251.88M | 263.25M | 273.52M | 273.52M | 292.65M | 289.63M | 301.40M | 338.81M | 249.43M |
| Shareholders' Equity | 188.76M | 186.25M | 186.69M | 178.47M | 172.50M | 159.83M | 155.21M | 161.45M | 150.73M | 145.39M | 402.96M | 387.76M |
| Retained Earnings | -183.80M | -185.75M | -180.73M | -183.47M | -185.07M | -188.94M | -188.94M | -178.41M | -180.97M | -183.49M | 71.95M | 70.70M |
| Total Debt | 66.09M | 67.50M | 68.44M | 69.38M | 70.31M | 71.25M | 72.19M | 73.13M | 74.06M | — | — | — |
| Net Cash (Debt) | -35.40M | -40.57M | -39.46M | -48.95M | -49.03M | -43.93M | -44.87M | -48.79M | -45.59M | 28.21M | 28.22M | 35.62M |
| Shares Outstanding | 5.60M | 5.52M | 5.52M | 5.51M | 5.50M | 5.46M | 5.46M | 5.42M | 5.41M | 5.39M | 5.39M | 5.39M |
This table shows 12 quarterly periods of Mesa Laboratories's balance sheet, from Q1 2027 back to Q2 2024, across 18 line items including cash & equivalents, receivables, inventory. Values in USD; B = billions, M = millions. Fiscal periods follow MLAB's reporting calendar. What is a balance sheet?